본문으로 건너뛰기
← 뒤로

Corrigendum to "Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study" [Eur J Cancer. 2025;228:115748].

0/5 보강
European journal of cancer (Oxford, England : 1990) 📖 저널 OA 14.4% 2021: 0/1 OA 2022: 0/1 OA 2023: 0/2 OA 2024: 1/8 OA 2025: 2/74 OA 2026: 27/116 OA 2021~2026 2025 Vol.230() p. 116010
Retraction 확인
출처

Tsukaguchi A, Matsumoto K, Tamiya A, Tamiya M, Mori M, Suzuki H

이 논문을 인용하기

↓ .bib ↓ .ris
APA Tsukaguchi A, Matsumoto K, et al. (2025). Corrigendum to "Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study" [Eur J Cancer. 2025;228:115748].. European journal of cancer (Oxford, England : 1990), 230, 116010. https://doi.org/10.1016/j.ejca.2025.116010
MLA Tsukaguchi A, et al.. "Corrigendum to "Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study" [Eur J Cancer. 2025;228:115748].." European journal of cancer (Oxford, England : 1990), vol. 230, 2025, pp. 116010.
PMID 41045692 ↗

같은 제1저자의 인용 많은 논문 (1)